European Journal of Clinical Investigation

Cover image for Vol. 42 Issue 5

May 2012

Volume 42, Issue 5

Pages 463–576


    1. Top of page
    1. Plasma myeloperoxidase level and peripheral arterial disease (pages 463–469)

      Helmuth Haslacher, Thomas Perkmann, Julia Gruenewald, Markus Exner, Georg Endler, Vanessa Scheichenberger, Oswald Wagner and Martin Schillinger

      Version of Record online: 23 SEP 2011 | DOI: 10.1111/j.1365-2362.2011.02601.x

    2. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease (pages 470–477)

      Leyla Ay, Florian Hoellerl, Cihan Ay, Johanna-Maria Brix, Silvia Koder, Gerit-Holger Schernthaner, Ingrid Pabinger and Guntram Schernthaner

      Version of Record online: 28 SEP 2011 | DOI: 10.1111/j.1365-2362.2011.02602.x

    3. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? (pages 478–486)

      Giovanna E. Carpagnano, Donato Lacedonia, Grazia P. Palladino, Anna Koutelou, Domenico Martinelli, Silvio Orlando and Maria P. Foschino-Barbaro

      Version of Record online: 28 SEP 2011 | DOI: 10.1111/j.1365-2362.2011.02603.x

    4. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL (pages 487–495)

      Paul J. W. H. Kappelle, Jan Freark de Boer, Frank G. Perton, Wijtske Annema, Rindert de Vries, Robin P. F. Dullaart and Uwe J. F. Tietge

      Version of Record online: 28 SEP 2011 | DOI: 10.1111/j.1365-2362.2011.02604.x

    5. An integrative view on the carotid artery alterations in metabolic syndrome (pages 496–502)

      Zhi-Hao Wang, Hui-Ping Gong, Yuan-Yuan Shang, Meng-Xiong Tang, Ning-Ning Fang, Gui-Hua Jiang, Yun Zhang, Ming Zhong and Wei Zhang

      Version of Record online: 28 SEP 2011 | DOI: 10.1111/j.1365-2362.2011.02605.x

    6. Effect of weight loss on C3 and C4 components of complement in obese patients (pages 503–509)

      Antonio Hernández-Mijares, Celia Bañuls, Lorena Bellod, Ana Jover, Eva Solá, Carlos Morillas, Víctor M. Víctor and Milagros Rocha

      Version of Record online: 10 OCT 2011 | DOI: 10.1111/j.1365-2362.2011.02606.x

    7. An observational study of endothelial function in early arthritis (pages 510–516)

      Will Foster, Gregory Y. H. Lip, Karim Raza, David Carruthers and Andrew D. Blann

      Version of Record online: 10 OCT 2011 | DOI: 10.1111/j.1365-2362.2011.02607.x

    8. Hepcidin expression in patients with acute leukaemia (pages 517–525)

      Pan-Pan Cheng, Zhen-Zhen Sun, Fang Jiang, Yue-Ting Tang and Xiao-Yang Jiao

      Version of Record online: 24 OCT 2011 | DOI: 10.1111/j.1365-2362.2011.02608.x

    9. Aliskiren reduces portal pressure in portal hypertensive rats (pages 526–533)

      Ching-Chih Chang, Wen-Shin Lee, Hui-Chun Huang, Fa-Yauh Lee, Sun-Sang Wang, Han-Chieh Lin, Jing-Yi Nong and Shou-Dong Lee

      Version of Record online: 24 OCT 2011 | DOI: 10.1111/j.1365-2362.2011.02611.x

    10. The impact of low serum sodium level on mortality depends on glycemic control (pages 534–540)

      Osman Z. Sahin, Gulay Asci, Fatih Kircelli, Mumtaz Yilmaz, Soner Duman, Mehmet Ozkahya, Cengiz Dogan, Ali R. Odabas, Mustafa Cirit and Ercan Ok

      Version of Record online: 3 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02613.x

    11. Impact of electrocardiographic interpretability on outcome in patients referred for stress testing (pages 541–547)

      Alberto Bouzas-Mosquera, Jesús Peteiro, Francisco J. Broullón, Elizabet Méndez, Gonzalo Barge-Caballero, Manuel López-Pérez, Angela López-Sainz, Nemesio Álvarez-García and Alfonso Castro-Beiras

      Version of Record online: 3 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02615.x

    12. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes (pages 548–556)

      Ana M. Blázquez-Medela, Luis García-Ortiz, Manuel A. Gómez-Marcos, José I. Recio-Rodriguez, Angel Sánchez-Rodríguez, José M. López-Novoa and Carlos Martínez-Salgado

      Version of Record online: 4 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02619.x

    13. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury (pages 557–563)

      Kenichi Manabe, Hiroshi Kamihata, Masayuki Motohiro, Takeshi Senoo, Susumu Yoshida and Toshiji Iwasaka

      Version of Record online: 10 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02620.x

    14. Use of atorvastatin to inhibit hypoxia-induced myocardin expression (pages 564–571)

      Chiung-Zuan Chiu, Bao-Wei Wang and Kou-Gi Shyu

      Version of Record online: 30 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02628.x


    1. Top of page
    1. Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls (pages 572–574)

      James J. Goedert, Ruth Pfeiffer, Mingzhu Zhu, Xiaohong R. Yang, Montserrat Garcia-Closas, Jolanta Lissowska and William C. Kopp

      Version of Record online: 11 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02610.x

    2. CD57 and γδ T-cell receptor expression in nodal metastatic spread of melanoma (pages 575–576)

      Iacopo Petrini, Cristian Scatena, Antonio G. Naccarato and Mario Petrini

      Version of Record online: 3 NOV 2011 | DOI: 10.1111/j.1365-2362.2011.02612.x